Infiltration of eosinophils into the asthmatic airways caused by interleukin 5.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Respiratory Cell and Molecular Biology

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1165/AJRCMB.16.3.9070605PMID 9070605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma.

  1994cited by this paper
• Clinical Investigations: Asthma/BronchodilatorsDetection of Cytokines and Their Cell Sources in Bronchial Biopsy Specimens From Asthmatic Patients: Relationship to Atopic Status, Symptoms, and Level of Airway Hyperresponsiveness

  1994cited by this paper
• IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.

  1993cited by this paper
• Interleukin-5 preferentially recruits eosinophils from vessels in nasal mucosa.

  1993cited by this paper
• Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma.

  1993cited by this paper
• Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs.

  1993cited by this paper
• Mechanism of airway inflammation in asthma.

  1993cited by this paper
• Interleukin-5, Eosinophils, and Disease

  1992cited by this paper
• Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach.

  1992cited by this paper
• Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.

  1992cited by this paper
• Application of monoclonal antibodies against major basic protein (BMK‐13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma

  1992cited by this paper
• Interleukin-5, eosinophils, and disease.

  1992cited by this paper
• Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung.

  1992cited by this paper
• Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

  1991cited by this paper
• The immunobiology of eosinophils.

  1991cited by this paper
• The eosinophil and bronchial asthma: current understanding.

  1990cited by this paper
• Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

  1990cited by this paper
• Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

  1989cited by this paper
• Recombinant human interleukin 5 is a selective activator of human eosinophil function

  1988cited by this paper
• Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

  1988cited by this paper
• The eosinophil and the pathophysiology of asthma.

  1986cited by this paper
• Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein

  1984cited by this paper

• Investigating the Therapeutic Effects and Mechanisms of Oroxylum indicum Aqueous Extract on Allergic Asthma Based on Ultra‐High‐Performance Liquid Chromatography–Quadrupole–Orbitrap–Tandem Mass Spectrometry, Network Pharmacology, and in vivo Experiments

  2025cites this paper
• Maternal diabetes promotes offspring lung dysfunction and inflammation in a sex-dependent manner.

  2022cites this paper
• Modulating Th2 Cell Immunity for the Treatment of Asthma

  2021cites this paper
• Ginger-derived compounds exert in vivo and in vitro anti-asthmatic effects by inhibiting the T-helper 2 cell-mediated allergic response

  2021cites this paper
• Effects of catalpol on asthma by airway remodeling via inhibiting TGF-β1 and EGF in ovalbumin-induced asthmatic mice.

  2020cites this paper
• Inhibitory effects of catalpol coordinated with budesonide and their relationship with cytokines and Interleukin-13 expression.

  2019cites this paper
• Effects of catalpol on bronchial asthma and its relationship with cytokines

  2018influential citation
• Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype

  2017cites this paper
• Catalpol alleviates ovalbumin‐induced asthma in mice: Reduced eosinophil infiltration in the lung

  2017cites this paper
• Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma

  2015cites this paper
• Caerulomycin A inhibits Th2 cell activity: a possible role in the management of asthma

  2015cites this paper
• Update on reslizumab for eosinophilic asthma

  2015cites this paper
• Dynamics of IL-4 and IL-13 expression in the airways of sheep following allergen challenge

  2015cites this paper
• Peripheral blood neutrophil and eosinophil activity during allergen-induced late-phase airway inflammation in asthma

  2015cites this paper
• Lung Inflammation Cells In Vivo, Thereby Regulating Allergic STAT6 Controls the Number of Regulatory T

  2013cites this paper
• Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma

  2013cites this paper
• STAT6 Controls the Number of Regulatory T Cells In Vivo, Thereby Regulating Allergic Lung Inflammation

  2013cites this paper
• Interleukins involved in asthma clinical trials . Interleukin Produced by Receptor Role in asthma Current status in drug development

  2012cites this paper
• Eosinophils in Human Disease

  2012cites this paper
• Targeting interleukins to treat severe asthma

  2012cites this paper
• Oral administration of Lactobacillus salivarius inhibits the allergic airway response in mice.

  2010cites this paper
• Th2 Cytokine Gene Locus Identifies Ets-1 as a Novel Regulator of the Phylogenetic and Functional Analysis

  2010cites this paper
• Natural killer cells in allergy

  2010cites this paper
• Th 2 Cytokine Gene Locus Identifies Ets-1 as a Novel Regulator of the Phylogenetic and Functional Analysis

  2010cites this paper
• Interleukin 5 in the link between the innate and acquired immune response.

  2009cites this paper
• IL-5- and eosinophil-mediated inflammation: from discovery to therapy.

  2009cites this paper
• Animal study for airway inflammation triggered by gastroesophageal reflux.

  2009cites this paper
• Phylogenetic and Functional Analysis Identifies Ets-1 as a Novel Regulator of the Th2 Cytokine Gene Locus

  2009cites this paper
• Preventive and curative glycoside kaempferol treatments attenuate the TH2-driven allergic airway disease.

  2009cites this paper
• Therapeutic potential of antibodies against interleukin 5 in asthma.

  2009cites this paper
• Oligonucleotide based-strategies for allergy with special reference to siRNA

  2009cites this paper
• THE REGULATION OF TH2 CYTOKINE GENES: FUNCTIONAL AND COMPARATIVE GENOMIC ANALYSIS

  2008cites this paper
• Novel Vaccination for Allergy through Gene Silencing of CD40 Using Small Interfering RNA1

  2008cites this paper
• Synergistic Effect of Various Regulatory Factors in Th1/Th2 Balance; Immunotherapeutic Approaches in Asthma

  2008cites this paper
• IL-5 and eosinophilia.

  2008cites this paper
• Intranasal delivery of whole influenza vaccine prevents subsequent allergen‐induced sensitization and airway hyper‐reactivity in mice

  2007cites this paper
• Bovine milk fat enriched in conjugated linoleic and vaccenic acids attenuates allergic airway disease in mice

  2007cites this paper
• CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma

  2006cites this paper
• Anti-Interleukin-5 Antibody Therapy in Eosinophilic Diseases

  2006cites this paper
• Increase in concentration of soluble CD86 after segmental allergen challenge in patients with allergic asthma.

  2006cites this paper
• Airway inflammation in asthma : from concept to the clinic

  2006cites this paper
• Common vaccine antigens inhibit allergen‐induced sensitization and airway hyperresponsiveness in a murine model

  2006cites this paper
• CD4+CD25+ regulatory T lymphocytes in allergy and asthma

  2005cites this paper
• Interleukin-5 reduces the expression of uteroglobin-related protein (UGRP) 1 gene in allergic airway inflammation.

  2005cites this paper
• CD4CD25 regulatory T lymphocytes in allergy and asthma.

  2005cites this paper
• Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice

  2003cites this paper
• Effect of antiallergic drugs on interleukin 5-induced eosinophil infiltration of rat airways.

  2002cites this paper
• Retinoic acid modulates IL-5 receptor expression and selectively inhibits eosinophil-basophil differentiation of hemopoietic progenitor cells.

  2002cites this paper
• Pathogenesis of asthma.

  2002cites this paper
• Synergistic Effect of Theophylline and Procaterol On Interleukin-5-Induced Degranulation from Human Eosinophils

  2002cites this paper
• Immunobiology of Asthma: Biotherapeutic Management

  2002cites this paper
• Role of IgE in Asthma Pathogenesis and Novel Therapeutic Strategies

  2002cites this paper
• Göğüsün Allerjik Hastalıklarında Bronkoalveolar Lavajın (BAL) Yeri-1: Astım ve BAL

  2002cites this paper
• IL‐5‐induced airway eosinophilia – the key to asthma?

  2001cites this paper
• Cytokine-directed therapies for asthma.

  2001cites this paper
• Interleukin-5: a novel target for asthma therapy

  2001cites this paper
• Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma.

  2001cites this paper
• Dexamethasone inhibits the binding of nuclear factors to the IL-5 promoter in human CD4 T cells.

  2001cites this paper
• Uterine Leiomyomas with Eosinophils: A Clinicopathologic Study of 3 Cases

  2001cites this paper
• Bronchial interleukin-5 and eotaxin expression in nasal polyposis. Relationship with (a)symptomatic bronchial hyperresponsiveness.

  2001cites this paper
• Clinical Significance of Rhinosinusitis in Severe Asthma and Its Management

  2001cites this paper
• [The current status of the study on asthma in China].

  2000cites this paper
• Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma

  2000cites this paper
• Apoptosis and airway inflammation in asthma

  2000cites this paper
• Advances in immunopharmacology of asthma.

  2000cites this paper
• New induction of leukotriene A(4) hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes.

  2000cites this paper
• Degranulating eosinophils in human endometriosis.

  2000cites this paper
• Effects of diesel organic extracts on chemokine production by peripheral blood mononuclear cells.

  1999cites this paper
• Effect of inhaled interleukin-5 on number and activity of eosinophils in circulation from asthmatics.

  1999cites this paper
• Role of IL–5 in the Development of Allergen–Induced Airway Hyperresponsiveness

  1999cites this paper
• Cytokines in asthma

  1999cites this paper
• Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects.

  1999cites this paper
• The late asthmatic response is associated with baseline allergen‐specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin‐5

  1999cites this paper
• Pharmacology of the eosinophil.

  1999cites this paper
• Eosinophil Survival and Activation Sulfonylureas Inhibit Cytokine-Induced

  1998cites this paper
• Inflammatory mediators of asthma: an update.

  1998cites this paper
• Cytokines dans l'inflammation allergique

  1998cites this paper
• Sulfonylureas inhibit cytokine-induced eosinophil survival and activation.

  1998cites this paper
• Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation.

  1998cites this paper
• Therapeutic effects of antibodies t interleukin‐5

  1998cites this paper
• Cytokine mRNA expression in asthma is not restricted to the large airways.

  1998cites this paper
• The Biological Function of Allergens: Relevant for the Induction of Allergic Diseases?

  1998cites this paper
• Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics.

  1998cites this paper
• Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics.

  1998cites this paper
• Cytokines and their receptors as therapeutic targets in asthma.

  1998cites this paper
• Airway hyperresponsiveness: first eosinophils and then neuropeptides.

  1997cites this paper
• Inhibition of interleukin‐5 with a monoclonal antibody attenuates allergic inflammation

  1997cites this paper
• Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways.

  1997cites this paper